9H-Purin-6-Amine Pharma Grade Coa Specifications
- Critical Identity: CAS 73-24-5, Molecular Weight 135.13, Formula C5H5N5.
- Quality Assurance: Rigorous HPLC purity verification exceeding 99.0% for antiviral intermediates.
- Supply Chain: Bulk procurement capabilities with full traceability and batch consistency.
In the landscape of pharmaceutical intermediate manufacturing, the reliability of raw materials dictates the success of downstream synthesis. 9H-Purin-6-amine, commonly known as Adenine, serves as a fundamental Nucleobase in the production of antiviral and antiretroviral agents. For process chemists and procurement officers, understanding the specific Certificate of Analysis (COA) requirements is essential to maintain industrial purity and regulatory compliance. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to strict specifications to ensure every batch meets the demands of complex synthesis route requirements.
This technical overview details the critical quality attributes, analytical verification methods, and consistency standards required for pharma grade procurement. Whether utilized in nucleotide analogs or as a standalone Purine base, the material must withstand rigorous scrutiny before entering the production line.
Certificate Of Analysis Requirements
A comprehensive COA is the primary document verifying the identity and quality of the chemical supply. For 6-Aminopurine (CAS 73-24-5), the COA must transcend basic identity checks and provide detailed quantitative data. Procurement teams should verify that the documentation includes specific physical constants and chemical assays that align with international pharmacopeia standards.
The following table outlines the typical specification limits expected for high-quality bulk supply:
| Parameter | Specification Limit | Test Method |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual |
| Identification (IR) | Consistent with reference standard | FT-IR Spectroscopy |
| Assay (Dry Basis) | ≥ 99.0% | HPLC |
| Loss on Drying | ≤ 0.5% | Karl Fischer / LOD |
| Residue on Ignition | ≤ 0.1% | Gravimetric |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
Each parameter listed above is critical for ensuring the material functions correctly in subsequent reactions. For instance, excessive moisture content can interfere with coupling reactions, while high residue on ignition may indicate inorganic contaminants that could poison catalysts. A valid COA provides the transparency needed to mitigate these risks before production begins.
HPLC Purity Verification
High-Performance Liquid Chromatography (HPLC) is the gold standard for assessing the chemical purity of 6-Amino-9H-purine. In industrial settings, area normalization methods are often employed, but for pharma grade materials, external standard calibration is preferred for accuracy. The chromatographic profile must demonstrate a single dominant peak corresponding to the main component, with related substances kept below strict thresholds.
Impurity profiling is particularly vital when the material is destined for antiviral synthesis. Related substances, such as unsubstituted purines or over-alkylated byproducts, can be difficult to remove in later stages. Therefore, the HPLC method should be validated to detect known process impurities at levels as low as 0.05%. At NINGBO INNO PHARMCHEM CO.,LTD., our quality control laboratories utilize gradient elution techniques to separate closely eluting peaks, ensuring that the reported industrial purity reflects the true chemical composition of the batch.
Furthermore, the detection wavelength is typically set between 254 nm and 260 nm to maximize sensitivity for the purine ring structure. Buyers should request representative chromatograms alongside the COA to verify peak resolution and baseline stability. This level of analytical detail supports the robust manufacturing process required for GMP-compliant production.
Batch Consistency Standards
Scaling from laboratory synthesis to commercial production often introduces variability. Maintaining batch-to-batch consistency is a hallmark of a reliable global manufacturer. For 6-Aminopurine, consistency is measured not only by assay but also by particle size distribution and bulk density, which affect handling and dissolution rates in reactor vessels.
Strict control over the synthesis route ensures that the crystalline form remains stable across different production runs. Variations in crystallization conditions can lead to different polymorphs, which may impact downstream processing. Therefore, manufacturers must document critical process parameters (CPPs) such as cooling rates, solvent ratios, and drying temperatures. These records ensure that every metric ton supplied matches the quality of the initial pilot batches.
When sourcing high-purity Adenine, buyers should prioritize suppliers who offer retain samples for every batch. This allows for independent verification and troubleshooting should any discrepancies arise during production. Consistency reduces the need for re-validation and ensures a stable supply chain for long-term projects.
Commercial Procurement and Bulk Pricing
The economic viability of pharmaceutical production depends heavily on the bulk price and availability of key intermediates. Market fluctuations can impact the cost of raw materials, but established manufacturers mitigate this through vertical integration and efficient logistics. Procurement strategies should focus on securing long-term contracts that lock in specifications and pricing tiers based on volume.
For large-scale operations, the ability to supply multi-ton quantities without compromising quality is non-negotiable. Suppliers must demonstrate capacity planning that aligns with the buyer's production schedule. Additionally, packaging options should be customizable, ranging from sealed drums for smaller batches to bulk bags for industrial use, all ensuring protection against moisture and contamination during transit.
In conclusion, securing 9H-Purin-6-amine with verified pharma grade specifications requires a partnership built on technical transparency and supply chain reliability. By prioritizing detailed COA review, rigorous HPLC verification, and batch consistency, manufacturers can ensure the integrity of their final pharmaceutical products. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to delivering high quality intermediates that meet the exacting standards of the global pharmaceutical industry.